Frontiers in Medicine (Aug 2022)
Case report: Cytokine hemoadsorption in a case of hemophagocytic lymphohistiocytosis secondary to extranodal NK/T-cell lymphoma
- Juan Carlos Ruiz-Rodríguez,
- Juan Carlos Ruiz-Rodríguez,
- Juan Carlos Ruiz-Rodríguez,
- Luis Chiscano-Camón,
- Luis Chiscano-Camón,
- Luis Chiscano-Camón,
- Adolf Ruiz-Sanmartin,
- Adolf Ruiz-Sanmartin,
- Adolf Ruiz-Sanmartin,
- Clara Palmada,
- Clara Palmada,
- Ivan Bajaña,
- Ivan Bajaña,
- Gloria Iacoboni,
- Gloria Iacoboni,
- Camilo Bonilla,
- Camilo Bonilla,
- Alejandra García-Roche,
- Alejandra García-Roche,
- Erika Paola Plata-Menchaca,
- Erika Paola Plata-Menchaca,
- Erika Paola Plata-Menchaca,
- Carolina Maldonado,
- Carolina Maldonado,
- Marcos Pérez-Carrasco,
- Marcos Pérez-Carrasco,
- Marcos Pérez-Carrasco,
- Mónica Martinez-Gallo,
- Mónica Martinez-Gallo,
- Mónica Martinez-Gallo,
- Mónica Martinez-Gallo,
- Clara Franco-Jarava,
- Clara Franco-Jarava,
- Manuel Hernández-González,
- Manuel Hernández-González,
- Manuel Hernández-González,
- Ricard Ferrer,
- Ricard Ferrer,
- Ricard Ferrer
Affiliations
- Juan Carlos Ruiz-Rodríguez
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Juan Carlos Ruiz-Rodríguez
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Juan Carlos Ruiz-Rodríguez
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Luis Chiscano-Camón
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Luis Chiscano-Camón
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Luis Chiscano-Camón
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Adolf Ruiz-Sanmartin
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Adolf Ruiz-Sanmartin
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Adolf Ruiz-Sanmartin
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Clara Palmada
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Clara Palmada
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Ivan Bajaña
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Ivan Bajaña
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Gloria Iacoboni
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Gloria Iacoboni
- Hematology Department, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Camilo Bonilla
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Camilo Bonilla
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Alejandra García-Roche
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Alejandra García-Roche
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Erika Paola Plata-Menchaca
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Erika Paola Plata-Menchaca
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Erika Paola Plata-Menchaca
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Carolina Maldonado
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Carolina Maldonado
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Marcos Pérez-Carrasco
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Marcos Pérez-Carrasco
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Marcos Pérez-Carrasco
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Mónica Martinez-Gallo
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- Mónica Martinez-Gallo
- Immunology Division, Vall d'Hebron University Hospital, Barcelona, Spain
- Mónica Martinez-Gallo
- Diagnostic Immunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain
- Mónica Martinez-Gallo
- Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain
- Clara Franco-Jarava
- Immunology Division, Vall d'Hebron University Hospital, Barcelona, Spain
- Clara Franco-Jarava
- Diagnostic Immunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain
- Manuel Hernández-González
- Immunology Division, Vall d'Hebron University Hospital, Barcelona, Spain
- Manuel Hernández-González
- Diagnostic Immunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain
- Manuel Hernández-González
- Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Barcelona, Spain
- Ricard Ferrer
- Intensive Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Ricard Ferrer
- Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- Ricard Ferrer
- Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain
- DOI
- https://doi.org/10.3389/fmed.2022.925751
- Journal volume & issue
-
Vol. 9
Abstract
We discuss a single case of Hemophagocytic lymphohistiocytosis (HLH) due to NK-type non-Hodgkin lymphoma and Epstein-Barr virus reactivation with multiorgan dysfunction and distributive shock in which we performed cytokine hemoadsorption with Cytosorb ®. A full microbiological panel was carried out, including screening for imported disease, standard serologies and cultures for bacterial and fungal infection. A liver biopsy and bone marrow aspirate were performed, confirming the diagnosis. The patients fulfilled the HLH-2004 diagnostic criteria, and according to the 2018 Consensus Statements by the HLH Steering Committee of the Histiocyte Society, dexamethasone and etoposide were started. There was an associated hypercytokinemia and, due to refractory distributive shock, rescue therapy with cytokine hemoadsorption was performed during 24 h (within day 2 and 3 from ICU admission). After starting this procedure, rapid hemodynamic control was achieved with a significant reduction in vasopressor support requirements. This case report highlights that cytokine hemoadsorption can be an effective since rapid decrease in IL-10 levels and a significant hemodynamic improvement was achieved.
Keywords
- hemophagocytic lymphohistiocytosis
- cytokine storm
- multiorgan dysfunction
- cytokine hemoadsorption
- shock